RCL
87
4
OKE
80
2
TXT
66
-3
MOS
46
-3
R
75
3
AA
63
7
TDC
70
15
DLTR
31
-3
BF.B
25
-3
BAX
36
-5
UAL
85
2
SIG
49
2
NWL
60
2
WY
56
3
KO
42
4
TAP
58
-2
WDC
50
-2
WHR
70
2
COST
66
6
MKC
54
4
RCL
87
4
OKE
80
2
TXT
66
-3
MOS
46
-3
R
75
3
AA
63
7
TDC
70
15
DLTR
31
-3
BF.B
25
-3
BAX
36
-5
UAL
85
2
SIG
49
2
NWL
60
2
WY
56
3
KO
42
4
TAP
58
-2
WDC
50
-2
WHR
70
2
COST
66
6
MKC
54
4
Financhill
Back

Neuberger Berman Intermediate Muni Fund Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
21

NBH
Neuberger Berman Intermediate Muni Fund

Last Price:
10.87
Seasonality Move:
2.52%
Buy
51

APLS
Apellis Pharmaceuticals

Last Price:
29.61
Seasonality Move:
22.1%
Sell
21
Neuberger Berman Intermediate Muni Fund (NBH) is a Sell

Is Neuberger Berman Intermediate Muni Fund a Buy, Sell or Hold?

  • The current Neuberger Berman Intermediate Muni Fund [NBH] share price is $10.90. The Score for NBH is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • NBH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Apellis Pharmaceuticals (APLS) is a Buy

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $30.02. The Score for APLS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NBH Stock Price Chart

What is Neuberger Berman Intermediate Muni Fund's stock price today?

  • The Neuberger Berman Intermediate Muni Fund share price today is $10.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBH is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $30.02
    The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 48.43 Sell
Chaikin Money Flow: 29211 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.8 - 11.08) Sell
Bollinger Bands (100): (10.79 - 11.19) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 58.06 Buy
Chaikin Money Flow: 2150169 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.93 - 28.43) Buy
Bollinger Bands (100): (29.7 - 39.56) Sell

NBH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.8 Buy
20-day SMA: 10.91 Sell
50-day SMA: 11.06 Sell
200-day SMA: 10.65 Buy
8-day EMA: 10.82 Buy
20-day EMA: 10.89 Buy
50-day EMA: 10.97 Sell
200-day EMA: 10.72 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.4 Buy
20-day SMA: 27.8 Buy
50-day SMA: 31.23 Sell
200-day SMA: 44.21 Sell
8-day EMA: 28.61 Buy
20-day EMA: 28.43 Buy
50-day EMA: 30.68 Sell
200-day EMA: 40.64 Sell

Neuberger Berman Intermediate Muni Fund Earnings Growth & NBH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Neuberger Berman Intermediate Muni Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):